Bill > HB2043

Introduced Session

As enacted, adds tianeptine and any salt, sulfate, free acid, or other preparation of tianeptine, and any salt, sulfate, free acid, compound, derivative, precursor, or preparation thereof that is substantially chemically equivalent or identical with tianeptine, as a schedule II controlled substance; specifies that a violation of the offense of knowingly possessing or casually exchanging a controlled substance (unless the substance was obtained directly from, or pursuant to, a valid prescription or order of a practitioner while acting in the course of professional practice), will be a Class A misdemeanor with respect to a person knowingly possessing or casually exchanging, tianeptine and any salt, sulfate, free acid, or other preparation of tianeptine and any salt, sulfate, free acid, compound, derivative, precursor, or other preparation thereof that is substantially chemically equivalent or identical with tianeptine. - Amends TCA Title 39, Chapter 17, Part 4.

Committee Categories

Mark Cochran (R)*,  Scott Cepicky (R),  Clay Doggett (R),  Bruce Griffey (R),  G.A. Hardaway (D),  Dan Howell (R),  William Lamberth (R),  Debra Moody (R),  Brandon Ogles (R),  John Ragan (R),  Lowell Russell (R),  Paul Sherrell (R), 

Comp. became Pub. Ch. 1135 (on 06/06/2022)

Official Document